Vaccine trends and Long covid

0 Просмотры


Cases, + 14,354 = 33,130,027

Deaths, + 437 = 592,776


At least one dose, (169 million)

Fully vaccinated, (137 million)

Vaccine trends


Global vaccination

President Biden

Pfizer, Moderna, J and J

80 million doses in June

First 25 million

6 million, Central and South America

7 million, Asia

5 million Asia

6 million, Allies in need

Mostly COVAX

Sinovac Biotech (CoronaVac)

Under licence in Pakistan as PacVac

Dr June Raine, the chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA).

We have carefully reviewed clinical trial data in children aged 12 to 15 years

and have concluded that the Pfizer/BioNTech Covid-19 vaccine

is safe and effective in this age group

and that the benefits of this vaccine outweigh any risk



Week ending 21 May 2021


England, (1 in 1,120)

Wales, (1 in 3,850)

NI, (1 in 820)

Scotland, (1 in 630)

These are likely to be compatible with variant , first identified in India.


+ 107 (7 days, certificated)

+ 151 previous week

below 5 year average

Long CoViD

In people with self-reported long COVID

More than one-third symptomatic after one year

2 May 2021

376,000 people infected during the “first wave” still symptomatic after one year

Out of million people with self-reported long COVID (more than 4 weeks)

Of those reporting Long CoViD

some limitation to day-to-day activities

day-to-day activities limited a lot

35 to 69 years, more likely to report long COVID 70+

Relatively more common in:


Deprived areas

Health or social care workers

Another activity-limiting health condition


Cases up on the week
Фантастика онлайн
Комментариев нет.